Markerless Liver Tumor Tracking during Radiotherapy Using Segment-Anything Model Based on Radiopaque Contrast Agent
Targeting accuracy in stereotactic ablative body radiotherapy (SABR) for hepatocellular carcinoma (HCC) is often hindered by the poor soft-tissue visibility of tumors on standard image-guided radiotherapy using kilovoltage (kV) images. However, ~60% of HCC pa...
Proffered Program · Therapy Physics